In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Kuhnil Pharmaceutical, Co. Ltd.

http://www.kuhnil.com/english/

Latest From Kuhnil Pharmaceutical, Co. Ltd.

Deal Watch: BioLineRx, Ono, Vedantra Ink Separate Cancer Immunotherapy Pacts

BioLineRx buys Agalimmune and its alpha Gal candidate for melanoma and possibly other oncology indications. Japan's Ono signs an R&D agreement with Switzerland's Numab, while Boston biotechs Vedantra and Neon will collaborate on potential cancer vaccines.

Commercial Deals

Deals Shaping the Medical Industry, January 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2016.

Deals BioPharmaceutical

Korea Chooses New Group Of Innovators For R&D Support

South Korea’s Ministry of Health and Welfare has unveiled a list of companies that will be designated as innovative pharma firms for the next three years and thus eligible to receive financial and tax incentives to boost their R&D activities.

BioPharmaceutical South Korea

Oakmont Pharmaceuticals

Generics and drug delivery

BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register